Most Recent

image: A Cancer Culprit in Autoimmunity

A Cancer Culprit in Autoimmunity

By | December 5, 2013

Scientists discover that cancer can drive the autoimmune disorder scleroderma.

0 Comments

image: Opinion: Of Mice and Men

Opinion: Of Mice and Men

By | December 3, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

image: Contributors

Contributors

By | December 1, 2013

Meet some of the people featured in the December 2013 issue of The Scientist.

0 Comments

image: Intracellular Spirals

Intracellular Spirals

By | December 1, 2013

Membrane twists connect stacked endoplasmic reticulum sheets.

0 Comments

image: Organelle Architecture

Organelle Architecture

By | December 1, 2013

There’s beauty in a cell’s marriage of structure and function.

1 Comment

image: Proto-Organelles for Synthetic Cells

Proto-Organelles for Synthetic Cells

By | December 1, 2013

Researchers construct lipid-encapsulated compartments within synthetic cells.

2 Comments

image: One Man's Trash...

One Man's Trash...

By | December 1, 2013

Scientists who dared to waste their time looking at the midbody, a remnant of cell division, have catapulted the organelle to new prominence.

2 Comments

image: Taking Shape

Taking Shape

By | December 1, 2013

The causes of a cell’s three-dimensional structure remain a fundamental mystery of cell biology.

7 Comments

image: Top 10 Innovations 2013

Top 10 Innovations 2013

By | December 1, 2013

The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

1 Comment

image: Week in Review: November 18–22

Week in Review: November 18–22

By | November 22, 2013

Chilly mice develop more tumors; gut bacteria aid cancer treatment; two Y chromosome genes sufficient for assisted reproduction; HIV’s “invisibility cloak”

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham